ASRT Assertio Holdings, Inc.: Accounting Book Value Bawat Bahagi

Assertio (ASRT) - korporatibong logo

Ang kalkuladong book value bawat siyer ng Assertio Holdings, Inc. (ASRT) ay nagpapakita ng kasalukuyang katatagan ng kapital, kung saan ang 11.71 indicator ay nagpapahayag ng estado ng metric. Ang paggalaw ng presyo ay nalilimitahan ng mga obligasyon sa utang at mga alitan sa patent, ngunit ang negosyo ay nakadepende sa isang matatag na domestic market ng US, habang binabalewala ang geopolitical na kaguluhan. Ang pragmatikong diskarte ng pamunuan sa mga transaksyon ng M&A at optimisasyon ng asset ay nagpapatunay sa kakayahan ng liderato sa pamamahala ng holding company.

Stockholders Equity Bawat Bahagi Assertio Therapeutics (ASRT): para sa panahong 04.07.2022 - 27.06.2026

Assertio Holdings - mga analytical breakdown at pangunahing sukatan (ASRT)

- presyo at pagtataya ng pinagkasunduang presyo:
Tsart ng Presyo Assertio Therapeutics|ASRT - Konsensus ng Makatarungang Halaga
- datos sa market capitalization:
Pagtatasa ng Merkado Assertio Holdings, Inc.|ASRT - Kabuuang Halaga ng Negosyo
- datos sa book capitalization:
Netong Asset Bawat Isang Bahagi Assertio|ASRT - Accounting Capitalization|Ratio ng Market Capitalization sa Book Value assertiotx.com|ASRT - Mga Asset ng Kumpanya
- datos sa utang at liquidity:
Ratio ng Kabuuang Utang sa Stockholders Equity Assertio Holdings, Inc.|ASRT - Pangmatagalang utang sa kapital|Panandaliang utang sa equity Assertio Therapeutics|ASRT - Mga pinagsamang obligasyon sa utang|Ratio ng utang sa book capitalization Assertio Holdings, Inc.
Fundamental valuation ng kumpanya:assertiotx.com, ASRT
Mga produktong ginagawa ng Assertio Therapeutics

Ang book value per share, na katumbas ng 11.71, ay sumasalamin sa bahagi ng net assets minus lahat ng liabilities, na nagtatakda ng intrinsic value ng security bawat unit. Sa pamamagitan ng pagsusuri sa trend ng book value per share, tinatasa ng isang investor ang capitalization ng drug portfolio ng Assertio Holdings, Inc. (ASRT), upang beripikahin kung gaano kaepektibong nakakapag-convert ang brand acquisition model at Indocin marketing tungo sa tunay na paglago ng equity.

Mga kakumpitensya ng Assertio Holdings, Inc. (ASRT)

Netong Asset Bawat Isang Bahagi Biogen Corp (BIIB)|Neurocrine Corp (NBIX) - Accounting Value ng Bahagi|RGC - Accounting Book Value Bawat Bahagi|AXSM (axsome.com) - Book Price ng Bahagi|Netong Asset Bawat Isang Bahagi ACADIA Pharmaceuticals Inc. (ACAD)|Stockholders Equity Bawat Bahagi Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Supernus Corp SUPN|Accounting Book Value Bawat Bahagi CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi AMLX|Trevi Corp (TRVI) - Net Asset Value Bawat Bahagi|PRAX (Praxis Precision Medicines) - Book Value Bawat Bahagi|Book Value Bawat Bahagi AVXL|CBLL (CeriBell) - Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi PRTA (Prothena Corporation)|Netong Asset Bawat Isang Bahagi ALEC|Net Assets Bawat Bahagi Annexon Biosciences Inc. ANNX|OMER (Omeros Corp.) - Book Value Bawat Bahagi|NGNE: Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi AC Immune SA ACIU|Accounting Value ng Bahagi Voyager Therapeutics Inc|Neumora Therapeutics Inc (NMRA) - Accounting Book Value Bawat Bahagi|Book Price ng Bahagi Scilex Holding Company, Inc.|TVGN (Tevogen Bio Holdings) - Book Value Bawat Bahagi|Net Assets Bawat Bahagi ACOG (alphacognition.com)|CGTX: Netong Asset Bawat Isang Bahagi|IKT - Net Asset Value Bawat Bahagi|Accounting Book Value Bawat Bahagi Cassava (SAVA)|COYA - Accounting Value ng Bahagi|Book Value Bawat Bahagi vistagen.com VTGN|OVID (Ovid Therapeutics) - Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi ABOS (Acumen Pharmaceuticals, Inc.)|Net Asset Value Bawat Bahagi CRVO|Netong Asset Bawat Isang Bahagi Alterity Therapeutics (ATHE)|Netong Asset Bawat Isang Bahagi clene.com (CLNN)|PEPG - Book Value Bawat Bahagi|Stockholders Equity Bawat Bahagi Jupiter Neurosciences, Inc. JUNS|Book Value Bawat Bahagi RLMD (Relmada Therapeutics, Inc.)|ANVS: Net Assets Bawat Bahagi|Netong Asset Bawat Isang Bahagi gracetx.com|Firefly Neuro (AIFF) - Stockholders Equity Bawat Bahagi|ANEW Medical - Book Value Bawat Bahagi|Book Value ng Isang Bahagi NRSN|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi metaviatx.com MTVA|Accounting Book Value Bawat Bahagi NeurAxis, Inc|Accounting Value ng Bahagi Helius Medical Technologies, Inc. HSDT|Book Value Bawat Bahagi PASG (Passage Bio Corp)|NEUP: Net Assets Bawat Bahagi|Netong Asset Bawat Isang Bahagi Minerva Neurosciences, Inc.|Athira Pharma Inc (ATHA) - Stockholders Equity Bawat Bahagi|Book Value Bawat Bahagi ADXN|Accounting Book Value Bawat Bahagi Alzamend (ALZN)|CYCN (Cyclerion Therapeutics) - Accounting Book Value Bawat Bahagi|Net Assets Bawat Bahagi protagenic.com (PTIX)|Book Value Bawat Bahagi KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi ATXI (Avenue Therapeutics, Inc)|BCLI: Net Assets Bawat Bahagi|Netong Asset Bawat Isang Bahagi Cara Therapeutics, Inc. CARA|Accounting Value ng Bahagi chromocell.com|Eliem Therapeutics, Inc. (ELYM) - Accounting Book Value Bawat Bahagi|Book Price ng Bahagi ITCI|Netong Asset Bawat Isang Bahagi Longboard Pharma LBPH|Stockholders Equity Bawat Bahagi Marinus Pharma (MRNS)|NKGN: Book Value Bawat Bahagi|NRBO - Net Asset Value Bawat Bahagi|Sage Therapeutics - Accounting Book Value Bawat Bahagi|SNPX: Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Trevena, Inc TRVN|VIGL (Vigil Neuroscience, Inc.) - Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi WENA (Anew Medical)|Net Asset Value Bawat Bahagi cerevel.com